ACHV(ACHV)
ACHV
ANALYST COVERAGE6 analysts
BUY
▲ +182.6%upside to target
PRICE
Prev Close
4.57
Open
4.54
Day Range4.45 – 4.75
4.45
4.75
52W Range2.00 – 6.15
2.00
6.15
63% of range
VOLUME & SIZE
Avg Volume
1.2M
FUNDAMENTALS
P/E Ratio
-4.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
0.67
Low vol
TECHNICAL
RSI (14)
45
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
PDividend Pay
In 97 days
Aug 26
ACHV News
About
achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Richard Stewart
Website
Richard A. StewartPresident, CEO & Executive Director
Jerry WanVice President of Finance & Principal Accounting Officer
Mark ZappiaSenior Vice President of Commercial
Nicole JonesVice President of Strategic Communications & Stakeholder Relations
Andrew D. GoldbergCEO, President & Director
Craig DonnellyChief Operations Officer
Erik AtkissonChief Legal Officer
Mark L. RubinsteinChief Medical Officer
Mark K. OkiChief Financial Officer
Jaime XinosChief Commercial Officer